THLD Financial Facts
General and administrative: 2.52MNet loss: -9.21M
See Full Income Statement
Additional paid-in capital: 310.6M
Accumulated other comprehensive gain (loss): 6K
See Full Balance Sheet
Earnings History for Threshold Pharmaceuticals, Inc. (THLD)
|
Expand Research on THLD
| Next EPS Date | 8/2/13 *Est. | EPS Growth Rate | +92.5% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -7.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.4% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/2/13 | Q113 | -$0.16 | -$0.09 | -$0.07 | $2.9M | $2.8M | N/A / N/A | N/A | +17.8% | Details | |
| 11/2/12 | Q312 | -$0.06 | -$0.06 | $0.00 | $1.8M | $2.29M | N/A / N/A | N/A | +35.9% | Details | |
| 5/3/12 | Q112 | -$2.12 | N/A | N/A | N/A | $15.65M | N/A / N/A | N/A | -16.6% | Details | |
| 11/3/11 | Q311 | -$0.08 | -$0.15 | +$0.07 | N/A | N/A | N/A / N/A | N/A | +261.7% | Details |
